Somatic alterations of RAS pathway genes, notably NRAS, KRAS, PTPN11 (missense mutations), and NF1 (mutations and deletions), are reported in up to 20% of AML cases [3]. The gene discussed is NRAS; the disease is acute myeloid leukemia.